Impairment of peripheral blood stem-cell mobilisation in patients with mantle-cell lymphoma following primary treatment with fludarabine and cyclophosphamide +/- rituximab.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples